| 标题 |
 Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1 mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet Neurology 作者：Pierre N Tariot; Ruijin Lu; Silvia Ríos-Romenets; Kaycee M Sink; Margarita Giraldo; et al 出版日期：2026-01-22 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
散逸层梦游
学术雷锋
吃葡萄不吐葡萄皮
Criminology34
北白川anko
飘逸的大雁
sanvva
Chinlu_Lee
sxlen
v0id
学霸业
无极微光
madeleinli
Gp1983
HuiLang
渡人舟
czx
宇王
dtg
皖公网安备34019202002308
